The striking temporal clustering of DM and cancer diagnosis when patients make an isolated immune response against only TIF1-γ suggests that the breadth of the immune response influences the pace of movement through the phases of immunoediting to escape (Figure 5, scenario A). The gene discussed is TRIM33; the disease is cancer.